Business Context and Reporting Period
This Form 8-K filing by The Carlyle Group L.P. (Carlyle) is dated October 23, 2017, reporting events effective January 1, 2018. The filing details a significant leadership transition involving the appointment of new Co-Chief Executive Officers and changes to the Board of Directors and Executive Group.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive appointments and compensation arrangements.
Material Changes Versus Prior Period
The primary material change is the restructuring of senior leadership effective January 1, 2018:
- New Co-CEOs: Kewsong Lee and Glenn A. Youngkin will become Co-Chief Executive Officers.
- Leadership Transitions: David M. Rubenstein and William E. Conway, Jr. will transition from Co-CEOs to Co-Executive Chairmen of the Board. Daniel A. D'Aniello will become Chairman Emeritus.
- Investment Leadership: William E. Conway, Jr. will become Co-Chief Investment Officer alongside Peter J. Clare, who is promoted from Managing Director and Deputy Chief Investment Officer.
- Board Composition: Messrs. Lee, Youngkin, and Clare will become members of the Board of Directors of Carlyle Group Management L.L.C.
Guidance, Outlook, and Compensation Arrangements
The filing outlines new five-year employment agreements for the Co-CEOs (Messrs. Lee and Youngkin) commencing January 1, 2018, designed to align their interests with investors.
- Base Salary: $275,000 annually for each Co-CEO.
- Annual Cash Bonus: Eligible for a bonus equal to distributions per common unit multiplied by 2,500,000 units.
- Equity Grants: Subject to Board approval in 2018, each Co-CEO will receive a one-time grant of 1,250,000 time-vesting deferred restricted common units (DRUs) and a performance-vesting DRU award with a target of 1,250,000 units. Performance DRUs can range from 0% to 200% of the target based on metrics set by the Board.
- Severance: In the event of termination without Cause or for Good Reason, Co-CEOs are entitled to cash severance equal to one year of base salary and Average Annual Bonus, plus 12 months of COBRA premiums.
- Restrictive Covenants: Includes 12-month non-solicitation and non-compete clauses following termination.
Important Facts for Investor Verification
- Verify the effective date of the leadership transition (January 1, 2018) and the specific roles of the incoming Co-CEOs.
- Confirm the Board's approval of the equity grants (1,250,000 time-vesting and 1,250,000 performance-vesting DRUs) scheduled for February 28, 2018.
- Review the performance metrics for the performance-vesting DRUs, which are to be set by the Board at the beginning of each performance year.
- Note the potential for additional vesting acceleration in the event of a Change of Control or termination without Cause.
- Understand that this filing contains no financial results; refer to the most recent Form 10-K or 10-Q for financial metrics.